Respiratory Disease Surveillance in the Middle East and Latin America during the COVID-19 Pandemic, 2020-2022

Emerg Infect Dis. 2024 Nov;30(14):26-32. doi: 10.3201/eid3014.240303.

Abstract

Characterizing the epidemiology of circulating respiratory pathogens during the COVID-19 pandemic could clarify the burden of acute respiratory infections and monitor outbreaks of public health and military relevance. The US Department of Defense supported 2 regions for influenza-like illness and severe acute respiratory infections surveillance, one in the Middle East through US Naval Medical Research Unit EURAFCENT, and another in Latin America through US Naval Medical Research Unit SOUTH. During 2020‒2022, coinciding with the COVID-19 pandemic, we collected a total of 16,146 nasopharyngeal and oropharyngeal swab samples from sentinel sites in Jordan (n = 11,305) and Latin America (n = 4,841). Samples were tested for SARS-CoV-2, influenza, and other respiratory pathogens. SARS-CoV-2 was the most frequently detected pathogen during 2020; other respiratory pathogens had distinct temporal and frequency distributions according to geographic location. Our findings support the need for continued sentinel surveillance as a vital tool for assessing the burden of respiratory diseases globally.

Keywords: COVID-19; Latin America; Middle East; SARS-CoV-2; influenza; respiratory infections; severe acute respiratory syndrome coronavirus 2; surveillance; viruses; zoonoses.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • COVID-19* / epidemiology
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Latin America / epidemiology
  • Male
  • Middle Aged
  • Middle East / epidemiology
  • Nasopharynx / virology
  • Pandemics
  • Respiratory Tract Infections / epidemiology
  • Respiratory Tract Infections / virology
  • SARS-CoV-2*
  • Sentinel Surveillance
  • Young Adult